SCHEMBL5983089

SCHEMBL5983089

COC1=CCC(C)(N)C=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL812575 0.82
SCHEMBL6984505 0.78
SCHEMBL8577723 0.76
SCHEMBL18334654 0.75
SCHEMBL28997121 0.75
SCHEMBL10288614 0.75
SCHEMBL9073650 0.75
SCHEMBL28629176 0.74
Hydrochloric Acid SCHEMBL30881387 0.74 HSD11B1 (0.31)
SCHEMBL12500608 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107011193-B Method for preparing N-methyl p-anisidine 中国科学院兰州化学物理研究所 2020-05-26 CN disclosed
WO-2009091388-A2 TRIAZINES AND RELATED COMPOUNDS HAVING ANTIVIRAL ACTIVITY, COMPOSITIONS AND METHODS THEREOF PROGENICS PHARMACEUTICALS, INC. (US) 2009-07-23 WO disclosed
EP-1654261-A1 HEPATITIS C INHIBITOR COMPOUNDS Boehringer Ingelheim International GmbH (DE) 2006-05-10 EP disclosed
WO-2004103996-A1 HEPATITIS C INHIBITOR COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2004-12-02 WO disclosed